Dexmedetomidine Completed Phase 4 Trials for Sufentanil (DB00708)

IndicationStatusPhase
DBCOND0050052 (Dexmedetomidine)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04791059Low-dose S-ketamine and Dexmedetomidine in Combination With Opioids for Postoperative AnalgesiaTreatment